Industry
Biotechnology
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
Loading...
Open
28.76
Mkt cap
3B
Volume
654K
High
29.65
P/E Ratio
-3.14
52-wk high
60.46
Low
28.52
Div yield
N/A
52-wk low
26.80
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.